In SCD juvenile patients, both an elevated reticulocyte count before HU therapy and a high leukocyte count thereafter have been identified as risk factors for reverting to insufficient TCD velocities [107,108,109,110]
While research on their long-term effects is ongoing, some studies suggest that these medications can positively impact metabolism and energy levels
In addition, two large-scale, double-blind, placebo-controlled phase 3 clinical studies called Evoke and Evoke + are underway to investigate the disease-mitigating potential of semaglutide in patients with AD with early symptoms and to explore its effects on AD biomarkers and neuroinflammation (Cummings et al., 2025)
Meet our Registered Dietitian Kelli Hanson, RD Kelli is a Registered Dietitian and Personal Trainer dedicated to helping clients achieve sustainable, healthy lifestyles
And its especially frustrating for those who feel mentally alert but physically incapable of doing more than the bare minimum
The cardiometabolic consequences of impaired glutathione homeostasis are profound
